Adverse Event Profiles of Platinum Agents: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations - Concepedia

Concepedia

Publication | Open Access

Adverse Event Profiles of Platinum Agents: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations

DOI Full Paper Access

67

Citations

8

References

2011

Year

Toshiyuki Sakaeda, Kaori Kadoyama, Yasushi Okuno

International Journal of Medical Sciences

Abstract

The results obtained herein were consistent with clinical observations, suggesting the usefulness of the FDA's adverse event reporting system, AERS, and the data mining method used herein.

References

	Year	Citations
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports Stephen Evans, Patrick Waller, Sarah Davis Pharmacoepidemiology and Drug Safety	2001	1.6K
A Bayesian neural network method for adverse drug reaction signal generation Andrew Bate, Marie Lindquist, I. Ralph Edwards, European Journal of Clinical Pharmacology EngineeringMachine LearningPredictive ToxicologyAdverse Drug ReactionBayesian Network	1998	1.3K
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions Eugène van Puijenbroek, Andrew Bate, Hubert G.M. Leufkens, Pharmacoepidemiology and Drug Safety	2002	1.2K
Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA??s Spontaneous Reports Database Ana Szarfman, Stella G. Machado, Robert T. O Neill Drug Safety Post-marketing SurveillanceEngineeringData ScienceData MiningClinical Database	2002	668
Practical pharmacovigilance analysis strategies A. Lawrence Gould Pharmacoepidemiology and Drug Safety	2002	153
Platinum Agent-Induced Hypersensitivity Reactions: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS Toshiyuki Sakaeda, Kaori Kadoyama, Hiroaki Yabuuchi, International Journal of Medical Sciences	2011	44
Toxicity of platinum compounds J�rg Thomas Hartmann, Hans‐Peter Lipp Expert Opinion on Pharmacotherapy OncologyMedicinePlatinum CompoundsPathologyOther Platinum Compounds	2003	39
Oxaliplatin-related side effects: Characteristics and management Jim Cassidy, Jean-Louis Misset Seminars in Oncology MedicinePharmacologyOxaliplatin-related Side EffectsClinical PharmacologyPharmacotherapy	2002	30

Page 1